Eastman Chemical (EMN) EBITDA (2009 - 2026)

Eastman Chemical (EMN) has 18 years of EBITDA data on file, last reported at $126.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 28.41% year-over-year to $126.0 million; the trailing twelve-month figure through Mar 2026 stood at $578.0 million (down 37.92% YoY), and the FY2025 full-year result was $628.0 million, down 30.99% from the prior year.
• EBITDA for Q1 2026 stood at $126.0 million, down from $275.0 million in the prior quarter.
• Across five years, EBITDA topped out at $294.0 million in Q4 2024 and bottomed at -$52.0 million in Q4 2022.
• The 5-year median for EBITDA is $205.0 million (2024), against an average of $189.2 million.
• The widest annual swing landed in 2022, when EBITDA slumped 113.3%; it then jumped 648.08% in 2023.
• A 5-year view of EBITDA shows it stood at -$52.0 million in 2022, then surged by 648.08% to $285.0 million in 2023, then grew by 3.16% to $294.0 million in 2024, then declined by 6.46% to $275.0 million in 2025, then tumbled by 54.18% to $126.0 million in 2026.
• The last three EBITDA figures came in at $126.0 million (Q1 2026), $275.0 million (Q4 2025), and $69.0 million (Q3 2025), per Business Quant data.

Peer Comparison